MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab.

Arnaud BourdinGeoffrey ChuppDavid J JacksonDavid CohenUlrika EmerathAnat ShavitYulia KurdyukovaAndrew Menzies-Gow

Published in: The journal of allergy and clinical immunology. In practice (2024)

This analysis demonstrated generally similar safety events between mepolizumab and benralizumab in patients with SEA.

Keyphrases